116 related articles for article (PubMed ID: 37983727)
1. LINC00355 promotes gastric carcinogenesis by scaffolding p300 to activate CDC42 transcription and enhancing HNRNPA2B1 to stabilize CDC42 mRNA dependent on m6A.
Chen H; Xiao L; Xie G; Zhang P; Dong P; Bian B; Wang J; Zhou Y; Ma Y; Liu Y; Shen L
Mol Carcinog; 2024 Mar; 63(3):430-447. PubMed ID: 37983727
[TBL] [Abstract][Full Text] [Related]
2. Exosomal LINC00355 promotes the malignant progression of gastric cancer through histone deacetylase HDAC3-mediated TP53INP1 transcriptional inhibition.
Zhao W; Zhang Y; Zhang W; Sun Y; Zheng B; Wang J; Gu Y; Qi J; Li J; Wang XJ; Chen J; Yang F
Life Sci; 2023 Feb; 315():121387. PubMed ID: 36640904
[TBL] [Abstract][Full Text] [Related]
3. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
4. LINC00355 inhibits apoptosis and promotes proliferation of gastric cancer cells by regulating Wnt/β-catenin signaling pathway.
Luan PB; Sun XM; Yao J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8377-8383. PubMed ID: 32894544
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.
Gao Z; Long Y; Wu Y; Pu Y; Xue F
Carcinogenesis; 2022 Jun; 43(5):419-429. PubMed ID: 35136989
[TBL] [Abstract][Full Text] [Related]
6. HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression.
Hu T; Zeng C; Song Z; Liu Q; Chen S; Huang W; Ma Q; Li H
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167050. PubMed ID: 38331110
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
8. HNRNPA2B1-mediated m
Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.
Xu P; Yang J; Chen Z; Zhang X; Xia Y; Wang S; Wang W; Xu Z
Cancer Commun (Lond); 2023 Jun; 43(6):685-705. PubMed ID: 37256823
[TBL] [Abstract][Full Text] [Related]
10. Long-term MNNG exposure promotes gastric carcinogenesis by activating METTL3/m6A/miR1184 axis-mediated epithelial-mesenchymal transition.
Liu T; Feng YL; Wang RY; Yang S; Ge YL; Zhang TY; Li J; Li CY; Ruan Y; Luo B; Liang GY
Sci Total Environ; 2024 Feb; 913():169752. PubMed ID: 38163601
[TBL] [Abstract][Full Text] [Related]
11. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract][Full Text] [Related]
12. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Eun JW; Kim HS; Shen Q; Yang HD; Kim SY; Yoon JH; Park WS; Lee JY; Nam SW
J Pathol; 2018 Jan; 244(1):107-119. PubMed ID: 28991363
[TBL] [Abstract][Full Text] [Related]
14. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
Li WJ; Li G; Liu ZW; Chen ZY; Pu R
Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
[TBL] [Abstract][Full Text] [Related]
16. LINC00355 induces gastric cancer proliferation and invasion through promoting ubiquitination of P53.
Zhao W; Jin Y; Wu P; Yang J; Chen Y; Yang Q; Huo X; Li J; De W; Chen J; Yang F
Cell Death Discov; 2020; 6(1):99. PubMed ID: 33083020
[TBL] [Abstract][Full Text] [Related]
17. LINC00355 promoted the progression of lung squamous cell carcinoma through regulating the miR-466/LYAR axis.
Sun X; Wang G; Ding P; Li S
Braz J Med Biol Res; 2020; 53(12):e9317. PubMed ID: 33111744
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
19. VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner.
Zheng ZQ; Huang ZH; Liang YL; Zheng WH; Xu C; Li ZX; Liu N; Yang PY; Li YQ; Ma J; Sun Y; Tang LL; Wei D
J Biol Chem; 2023 May; 299(5):104677. PubMed ID: 37028765
[TBL] [Abstract][Full Text] [Related]
20. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.
Han H; Fan G; Song S; Jiang Y; Qian C; Zhang W; Su Q; Xue X; Zhuang W; Li B
Blood; 2021 Mar; 137(12):1603-1614. PubMed ID: 32967010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
